Important matters:
Yadi Holdings (01585) subsidiary plans to acquire all shares of Wuxi Lingbo Electronic Technology for 352 million yuan
Kingsley Biotechnology (01548): CARVYKTI was recommended by the US FDA Oncology Drug Advisory Committee for early treatment of patients with recurrent or refractory multiple myeloma
Cornerstone Pharmaceutical-B (02616) announced that the fifth indication for sugarimab has been approved in China for first-line treatment of gastric cancer
Operating performance:
Sinopec Refining & Chemical Engineering (02386) Announces 2023 Annual Results Profit attributable to shareholders of 2,335 billion yuan, a year-on-year increase of 2.2%, and plans to pay a final dividend of 0.224 yuan per share
Baiyunshan (00874) announced its annual results, and net profit of 4,056 billion yuan increased 2.25% year-on-year
China Resources Building Materials Technology (01313) announced annual results. Profit attributable to shareholders of $644 million decreased by 60.1% year-on-year, with final interest of HK$0.006 per share
Dongyao Pharmaceutical-B (01875) achieved revenue of 781 million yuan in 2023, a year-on-year increase of 77%, and continued improvement in profitability
Fuyao Glass (03606) announced annual results. The profit to mother was about 5.629 billion yuan, an increase of 18.37% over the previous year. It plans to pay a dividend of 1.3 yuan per share
Meitu (01357) Announces 2023 Annual Results Profit attributable to shareholders of $378 million, a year-on-year increase of 301.8% with a final dividend of HK$0.036 per share
China Aviation Technology (02357) announced 2023 results, net profit attributable to mother was 2,447 billion yuan, up 5.47% year-on-year
Chinese Real Estate (00127) Announces 2023 Results Profit attributable to owners of HK$76.832 million decreased by 93.33% year-on-year